Spratt, D. E.; Alshalalfa, M.; Fishbane, N.; Weiner, A. B.; Mehra, R.; Mahal, B. A.; Lehrer, J.; Liu, Y.; Zhao, S. G.; Speers, C.; Morgan, T. M.; Dicker, A. P.; Freedland, S. J.; Karnes, R. J.; Weinmann, S.; Davicioni, E.; Ross, A. E.; Den, R. B.; Nguyen, P. L.; Feng, F. Y.; Lotan, T. L.; Chinnaiyan, A. M.; Schaeffer, E. M.
Transcriptomic heterogeneity of androgen receptor (AR) activity defines a de novo low AR-active subclass in treatment naive primary prostate cancer.
Clin Cancer Res
(2019)
In process.
PMID: 31515456.
Ahmed, A.; Merrill, S. A.; Alsawah, F.; Bockenstedt, P.; Campagnaro, E.; Devata, S.; Gitlin, S. D.; Kaminski, M.; Cusick, A.; Phillips, T.; Sood, S.; Talpaz, M.; Quiery, A.; Boonstra, P. S.; Wilcox, R. A.
Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.
Lancet Haematol
(2019)
In process.
PMID: 31537486.
Lang, X.; Green, M. D.; Wang, W.; Yu, J.; Choi, J. E.; Jiang, L.; Liao, P.; Zhou, J.; Zhang, Q.; Dow, A.; Saripalli, A. L.; Kryczek, I.; Wei, S.; Szeliga, W.; Vatan, L.; Stone, E. M.; Georgiou, G.; Cieslik, M.; Wahl, D. R.; Morgan, M. A.; Chinnaiyan, A. M.; Lawrence, T. S.; Zou, W.
Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11.
Cancer Discov
(2019)
In process.
PMID: 31554642.
Jordahl, S.; Solorio, L.; Neale, D. B.; McDermott, S.; Jordahl, J. H.; Fox, A.; Dunlay, C.; Xiao, A.; Brown, M.; Wicha, M.; Luker, G. D.; Lahann, J.
Engineered Fibrillar Fibronectin Networks as Three-Dimensional Tissue Scaffolds.
Adv Mater
(2019) PMID: 31565823.